Over the course of its 25 years in the neuroscience industry, Magstim has been a pivotal tool in the advances of transcranial
magnetic stimulation for researchers across the globe.
magnetic stimulation (TMS) emerges as a therapeutic tool with clinical benefits in neurological and psychiatric diseases.
A team of US researchers has shown that transcranial
magnetic stimulation of the brain can help improve memory.
Axilum Robotics, specialized in the development of medical robots, reports the publication in PLOS ONE of the first human Brain to Brain communication experiment, using non- invasive techniques and without contribution of the peripheral nervous system, whose success was ensured thanks to its new robot for Transcranial
Magnetic Stimulation (TMS).
Most recently, Donato has served as the chief financial officer at Neuronetics, a Transcranial
Magnetic Stimulation therapy company.
National contract notice: transcranial
NuMe TMS Clinics announced BrainsWay's Deep Transcranial
Magnetic Stimulation therapy for both Major Depressive Disorder and Obsessive-Compulsive Disorder (OCD), will be available to residents in the Houston area.
Recently, additional neuromodulatory approaches have been FDA-cleared, including transcranial
magnetic stimulation (TMS), vagus nerve stimulation (VNS), and deep brain stimulation (DBS).
magnetic stimulation (rTMS) changes cortical excitability and modulates brain activity across distributed neural networks beyond the duration of stimulation itself. More recently, a new pattern of rTMS, called theta burst stimulation (3 pulses at 50 Hz repeated at 200 ms intervals), has been developed as a method to induce long-lasting changes in cortical excitability with less stimulation.
The brain stimulation method comprises of repetitive Transcranial
Magnetic Stimulation (rTMS) and Transcranial
Current Stimulation (tCS).
magnetic stimulation (dTMS) has shown promise in the treatment of depression, obsessive-compulsive disorder, and other mental health disorders, and a study has found that this non-invasive treatment also may be effective in alleviating multiple sclerosis (MS) symptoms.
The Food and Drug Administration has cleared the way for marketing of the Brains Way deep transcranial
magnetic stimulation system for treating patients with treatment-resistant obsessive-compulsive disorder (OCD).